Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-19
2008-10-07
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253050, C514S253060, C514S254020, C544S360000, C544S363000, C544S369000
Reexamination Certificate
active
07432269
ABSTRACT:
The invention relates to compounds of the general formula (I):to the process for preparing them, and to the use thereof as a therapeutic agent having the property of being selective ligands for the dopamine D3 receptor. These selective D3 ligands are useful as medicines in neuropsychiatry, in particular in the treatment of psychotic or depressive states, or in the treatment of motor disorders, such as dyskinesia or essential tremor. They are furthermore useful in the treatment of dependency on nicotine, cocaine, alcohol, opioids and for facilitating withdrawal in drug-dependent individuals.
REFERENCES:
patent: 6224849 (2001-05-01), Kennis et al.
patent: 2002/0052496 (2002-05-01), He et al.
patent: 2005/0043309 (2005-02-01), Clark et al.
patent: 2 258 561 (1973-06-01), None
patent: WO-98/56786 (1998-12-01), None
patent: WO-00/18767 (2000-04-01), None
patent: 8504887 (1986-02-01), None
Yang et. al.; Raney Nickel; Apr. 15, 2006; Encyclopedia of Reagents for Organic Synthesis; p. 1-21.
Roden et. eal.; Hydrazine; Apr. 15, 2001; Encyclopedia of Reagents for Organic Synthesis; p. 1-9.
Vaquero et. al.; The Reactions of Benzomalononitriles with Hydrazine and Hydroxylamine. Synthesis of Pyrazoles, Isoxazoles, and Pyrazolo[1,5-a]-pyrimidine Derivatives.
Vippagunta, et. al., Advanced Drug Delivery Reviews; 48, (2001) 3-26.
Berrebi-Bertrand Isabelle
Calmels Thierry
Capet Marc
Danvy Denis
Lecomte Jeanne-Marie
Bioprojet
Murray Jeffrey H
Schulman B. Aaron
Stites & Harbison PLLC
Wilson James O.
LandOfFree
Arylpiperaszine derivatives, to the process for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylpiperaszine derivatives, to the process for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylpiperaszine derivatives, to the process for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012083